SBC Medical Group Holdings Incorporated (SBC) Stock Forecast
SBC analyst forecast
as of October 18, 2026- Analyst consensus
- Strong buy 4.67 / 5 from 3 analysts
- Price target
- $8.75 average of analyst targets
- Upside to target
- +69.6% from the latest close
- Next earnings
- November 13, 2026 EPS estimate $0.11
- 52-week range
- $2.87 – $5.42
SBC analyst ratings
3 analystsNumber of analysts at each rating.
SBC price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
SBC earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.12 | $0.10 | $0.13 | $0.12 | −2.1% | 4 |
| Current fiscal year (2026) | $0.46 | $0.42 | $0.48 | $0.50 | −8.0% | 4 |
| Next fiscal year (2027) | $0.54 | $0.52 | $0.56 | $0.46 | +17.4% | 2 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
SBC revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $48.9M | $44.4M | $52.0M | +12.8% | 5 |
| Current fiscal year (2026) | $191.0M | $182.5M | $197.8M | +10.0% | 5 |
| Next fiscal year (2027) | $210.4M | $192.4M | $222.6M | +10.1% | 4 |
SBC EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
SBC revenue: reported and forecast
SBC EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | −2.1% | 2 up · 2 down |
| Current fiscal year (2026) | $0.47 | $0.47 | $0.46 | $0.46 | $0.46 | −1.1% | 2 up · 2 down |
| Next fiscal year (2027) | $0.48 | $0.48 | $0.54 | $0.54 | $0.54 | +11.3% | 2 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
SBC earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; SBC beat in 4 of 8.
What analysts expect from SBC
3 analysts cover SBC Medical; their consensus rating is strong buy (4.67 on a 1–5 scale, where 5 is a strong buy). The average price target is $8.75, 69.6% above the latest close of $5.16. Analysts expect earnings of $0.46 per share for 2026, −8.0% from a year earlier. For 2027 the average estimate is $0.54 per share on revenue of $210.4 million. SBC Medical beat the EPS estimate in 4 of the last 8 quarters.
Related: SBC income statement, SBC key metrics, SBC chart. See the SBC stock overview for the latest quote and news.
SBC forecast FAQ
What is SBC Medical's price target?
The average analyst price target for SBC Medical is $8.75, 69.6% above the latest close of $5.16.
Is SBC Medical a buy, hold or sell?
Of 3 analysts covering SBC Medical, 2 rate it a strong buy, 1 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is SBC Medical's EPS forecast?
Analysts forecast $0.46 per share for 2026 (range $0.42 to $0.48); for 2027 the estimate is $0.54.
What is SBC Medical's revenue forecast?
The average revenue estimate for 2026 is $191.0 million, growth of 10.0%; for 2027 it is $210.4 million.
When does SBC Medical report earnings?
SBC Medical is expected to report results for the quarter ending September 30, 2026 on November 13, 2026 before the market opens; the EPS estimate is $0.11.
Does SBC Medical usually beat earnings estimates?
SBC Medical reported EPS at or above the analyst estimate in 4 of the last 8 quarters.